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Background: Port-A catheters are frequently used in pediatric cancer patients. Their dislodgement is potentially
seriously risky although the incidence is not high. We analyzed our 11 years of data to address this important
problem.
Methods: From January 2001 to December 2011, 330 port-A catheters of different brands were implanted in
pediatric cancer patients. In total, eight children suffered a dislodgement of their catheter. Their ages ranged from
four to thirteen years, with a median age of ten. Five patients presented with catheter dysfunction, two presented
with a cough and one was identified incidentally during surgery to remove his port.
Results: The downstream ends of the dislodged catheters were located in the right atrium (three patients), left
pulmonary artery (three) and inferior vena cava (two). Six of the eight catheters were broken at the site of
anastomosis to the port and the other two were broken halfway in between. All episodes of dislodgement
happened after the chemotherapy regimen was completed. The dislodged catheters were successfully retrieved
without complications by transcatheter retrieval using a gooseneck snare.
Conclusions: The dislodgment rate of port-A catheter in our series was 2.4%. Chest X-rays can rapidly detect the
problem. Most of the catheters were broken at the site of anastomosis. Earlier explantation of port-A catheters after
completing chemotherapy may be considered to avoid the dislodgement of catheters, but this needs to be
weighed against the possibility of underlying disease recurrence. However, we should re-examine how long port-A
catheters need to be retained after chemotherapy considering the improved cure rate of pediatric cancer.
Keywords: Children, Dislodgement, Port-A catheter, Transcatheter retrievalBackground
Totally implanted central venous access catheters (for ex-
ample, the Port-A-Cath) can provide reliable, long-term
vascular access for chemotherapy, total parenteral nutri-
tion and frequent blood sampling [1]. They are commonly
used in patients with hematologic or oncologic disorders.
They significantly improve the quality of life for pediatric
oncologic patients with difficult intravenous access [1].
Complications, such as infection and thrombosis, with
port-A catheters are not uncommon [2]. The dislodge-
ment and migration of a catheter is a rare but potentially* Correspondence: ray.sheen@gmail.com
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reproduction in any medium, provided the orserious complication. In this study, we investigated the in-
cidence and clinical presentation as well as the risk factors
of catheter dislodgements to prevent their occurrence.Methods
We reviewed the medical records of patients who received
replacement port-A catheters from 1 January 2001 to 31
December 2011, and followed up the clinical course until
30 June 2012. This study was approved by the Institution
Review Board of the hospital. There were 330 totally im-
planted catheters of different brands implanted in 297
pediatric cancer patients. Of these, twenty-six patients had
a catheter implanted twice, two patients three times and
one patient four times.
In total, eight children suffered dislodgement and migra-
tion of a catheter. Five patients presented with cathetertd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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1 4 F 19 Lymphoma 5/1 R 2 1 Cough RPA – LPA Middle
2 12 F 34 ALL 37/8 R 3 2 Dysfunction SVC – IVC Anastomosis
3 6 M 25 ALL 47/16 R 1 1 Incidentally at
operation
SVC – RA Anastomosis
4 13 M 56 AML 45/34 L 3 2 Cough, fever,
incidentally
RV – LPA Anastomosis
5 13 M 78 AML 38/9 R 1 1 Dysfunction LPA – LPA Anastomosis
6 9 F 17 US 31/18 R 1 3 Dysfunction Right brachiocephalic
vein – IVC
Anastomosis
7 9 F 28 RMS 26/10 L 3 2 Dysfunction Left brachiocephalic
vein – RA
Anastomosis
8 5 F 18 IT 17/4 R 1 4 Dysfunction Hepatic vein – RA Middle
ALL, acute lymphoblastic leukemia; AML, acute myeloblastic leukemia; F, female; IT, immature teratoma; IVC, inferior vena cava; L, left; LPA, left pulmonary artery; M, male; R, right; RA, right atrium; RMS, rhabdomyosarcoma; RPA,




















Figure 1 Chest radiogram in case 7 showing the port-A
catheter broken at the site of anastomosis to the port. The loop
of the gooseneck snare has caught the dislodged catheter.
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was identified incidentally during surgery for removal of
his port-A catheter. All dislodged catheters were success-
fully retrieved without complication by transcatheter re-
trieval through the femoral route using a gooseneck snare
and one with additional pigtail help. We used chi-squared
or Fisher’s exact tests to compare categorical variables. We
used Student’s t test to compare continuous variables. A P
value less than 0.05 was considered statistically significant.Results
The data for the patients suffering catheter dislodgements
and migration are summarized in Table 1. There were five
girls and three boys. Their ages ranged from 4 to 13 years,Figure 2 Chest radiograms for case 8. (A) Port-A-Cath catheter before d
fragment migrated to the hepatic vein and right atrium (arrows).with a median of 10 years of age. Their body weights
ranged from 17 to 78 kg, with a median of 27 kg. Four
patients were diagnosed with acute leukemia, two with
sarcoma, one with lymphoma and one with immature
teratoma. The duration of catheter use was from 5 to
47 months, with a median of 34 months. All episodes of
dislodgement happened after the chemotherapy regi-
men was completed. These patients had all been off
chemotherapy for a median of 9.5 months (range 1 to
34 months). Six catheters were located over the right
side, two on the left side. The puncture sites were the
internal jugular vein in four children, the subclavian
vein in three and the external jugular vein in one. There
were dislodgements for all four brands and brands
Arrow and Bard had three each. The downstream ends
of the dislodged catheters were located in the right
atrium (three patients), left pulmonary artery (three)
and inferior vena cava (two). Six of the eight catheters
were broken at the site of anastomosis to the port and
the others were broken halfway to the port (Figure 1
and Figure 2).
Next, we compared the clinical characteristics of the
eight patients who suffered a catheter dislodgement and
322 patients who did not (Table 2). There was no signifi-
cant statistical difference in sex, age, duration of use,
diagnosis, laterality, vein inserted and operating surgeon
between these two groups. Only the port-A brand (Arrow
to Vortex) had a significant difference. Because all epi-
sodes of dislodgement in our patients happened after the
chemotherapy regimen was completed, we compared the
relation between chemotherapy status and port-A-catheter
dislodgement. We found the off chemotherapy group had
a higher dislodgement rate statistically. For the 190 pa-
tients off chemotherapy, there was no difference between
the ‘off chemotherapy less than half year group’ and ‘off
chemotherapy longer than half year group’ (Table 3).Discussion
The rate of dislodgement of port-A catheters is 1.4% to
3.6% in children [3,4], which is higher than the 0.3% toislodgement. (B) The catheter broke halfway to the port and the







(N = 322) (N = 8)
Age at insertion (months) 90.2 ± 3.5 82.4 ± 12.5 0.565
Sex (number) (M:F)a 189 : 133 3 : 5 0.402





Brain tumor 24 0







Laterality (R:L)a 248:74 6:2 1
Vein inserted
Internal jugular 241 4 0.286








ALL, acute lymphoblastic leukemia; AML, acute myelogeneous leukemia; F,
female; L, left; M, male; R, right.
a Sex and laterality are expressed as ratios, other parameters are expressed as
means ± standard error of the mean.
b Arrow to Vortex: P = 0.006.
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is similar to previous research. For a child, the surgeon
usually cuts the catheter and connects it to the port be-
cause the body size varies in pediatric patients, which
might account for the higher incidence of dislodgment
in children, especially at the site of anastomosis, a fre-
quent site of dislodgement [7]. Nevertheless, the period
of use has to be taken into consideration because chil-
dren with cancer have a better survival rate and a longer
treatment period than adult patients.Table 3 Relation between chemotherapy status and port-A ca
Factor (number of patients with dislodgement/number of patients with
Under chemotherapy (0/330) vs. off chemotherapy (8/190)
Off chemotherapy less than 1/2 year (2/19) vs. > 1/2 year (6/171)In theory, any dislodgement of a catheter should cause
catheter dysfunction. The dislodgement for one patient
in our series, however, was found incidentally during
surgery to remove his port and two patients in our series
presented with coughing. This may be because the pa-
tients did not receive regular flushing of the port when
the catheter was not being used. Although most dis-
lodgements present with only irrigation resistance or
even without symptoms or signs [8], critical conditions
such as ventricular tachycardia secondary to port-A frac-
ture and embolization still need to be watched for [9].
We have no exact data that would indicate the percent-
age of port dysfunction caused by catheter dislodgement
but chest radiography can validly detect catheter dis-
lodgment. Chest radiography was needed to be taken be-
fore surgery for removal of a port to avoid dislodgement
just found during operation in those without regular
flushing.
The downstream ends of the dislodged catheters were
located in the right atrium (three patients), the left pul-
monary artery (three) or the inferior vena cava (two).
Tsai et al. reported that the most frequent location of
dislodged port-A catheters was between the right atrium
and inferior vena cava [10]. The most commonly used
retrieval set is the loop snare. Cheng et al. reported that
the success rate for percutaneous retrieval of the dislodged
fragment was 97.8% and the complication rate was only
3.3% [8]. Therefore the retrieval of dislodged port-A cath-
eters using an endovascular approach might be the first
choice of treatment because it is both safe and effective.
The causes of catheter dislodgment include poor con-
nection to the port, catheter damage at the site of anas-
tomosis, incorrect catheter position, catheter damage by
chemotherapeutic drugs and the pinch-off syndrome
[11,12]. The pinch-off syndrome occurs when a subclavian
catheter passes between the clavicle and the first rib and
becomes compressed or kinked [13]. Over time, the cath-
eter may become damaged or even broken. This syndrome
occurs in up to 40% of adult patients with catheter dis-
lodgments [13]. In our series, all six catheters that dis-
lodged at the anastomotic site between the port and the
catheter were damaged and torn at the fracture site, prob-
ably owing to material fatigue after long-term use, angula-
tion or exposure to chemotherapeutic drugs. A short
residual piece of catheter connected to the port was noted
during surgical removal. Furthermore, our cases ranged
between 4 and 13 years old and were growing continu-
ously. A tensile force may further draw the catheter outtheter dislodgement
out) % vs.% P value
0 vs. 4.2 < 0.001
10.5 vs. 3.5 0.184
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tween the port and its flexed portion in order to cope with
the child’s physical growth. Only two of the broken cathe-
ters were not broken at the anastomosis site. Neither of
these two broken catheters was punctured at the subclavian
vein, indicating classical pinch-off syndrome is not likely
the cause of catheter broken. We also found that these two
catheters had broken earlier than the other six catheters.
Whether the catheters were broken by kinking or compres-
sion while turning the head is to be determined.
Chang et al. stated that a cephalic vein cut-down per-
formed by a general surgeon had a lower risk of catheter
fragmentation than a subclavian vein puncture through the
Seldinger technique performed by a vascular surgeon [12].
Wu et al. also indicated that intravenous port implantation
via the subclavian route and the Arrow Fr. 8.1 port were
found to be risk factors [14]. Lin et al. stated that the ceph-
alic vein or jugular vein cut-down technique should be used
to avoid the pinch-off syndrome; they emphasized that a
port-A catheter should be placed in a natural axis or pos-
ition, and the junction between the connector and the cath-
eter should not be bent [15]. In this study, we compared
the clinical characteristics of patients with or without cath-
eter dislodgement. We found that the only risk factor was
the port-A brand (Arrow to Vortex). This is compatible
with Wu et al., yet the number of our cases with the Arrow
brand was too small to make this conclusion. Interestingly,
all episodes of dislodgement in our patients happened after
the chemotherapy regimen was completed. The definite
cause is not known. During the course of chemotherapy
the intravenous dripping has a lower pressure than the
bolus flush used after completing the course. This higher
pressure is one possible cause. However, there are still
many factors to be considered in our study, for example,
the installation of the port chamber and the handing proto-
cols of catheters.
Without doubt, early explantation of a port-A catheter
will definitely prevent related complications. There are still
reasons to retain the device during the post-treatment sur-
veillance since cancer patients require further follow-up to
rule out recurrence. In our series, there were 144/330 cases
of intentional removal of a port-A catheter. Three of these
cases needed re-implantation of the port-A catheter. These
three patients were all diagnosed with acute lymphoblastic
leukemia relapse. They were off chemotherapy for 19, 27
and 24 months, respectively. The intervals from explan-
tation of the old port-A catheter to implantation of the
new one were 59, 66 and 61 months, respectively. Further-
more, it may be a challenge to find new vascular access
in patients with previous central venous lines or who had a
port-A catheter removed. However, with the improved
cure rate of pediatric cancer, we should re-examine how
long port-A catheters need to be retained after the comple-
tion of chemotherapy.Conclusions
The dislodgment rate of port-A catheters in our series was
2.4%. Chest X-rays can rapidly detect the problem. Most
catheters were broken at the site of anastomosis. Earlier
explantation of a port-A catheter after completion of che-
motherapy may avoid dislodgement and migration of the
catheter but the possibility of underlying disease recur-
rence needs to be considered.
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